Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VIMPAT ® safely and effectively. See full prescribing information for VIMPAT. VIMPAT ® (lacosamide) oral solution, CV Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
VIMPAT is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. As the safety of VIMPAT injection in pediatric patients has not been established, VIMPAT injection is indicated for the treatment of partial-onset seizures only in adult patients (17 years of age and older).
- generic_name
- lacosamide
- product_names
- lacosamide
- ndc
- 70166-617, 0131-5410, 70166-617-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en